Cargando…
Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States
Background: The Intercept Blood System (IBS) for platelets has been developed to reduce pathogen transmission risks during transfusions. Objective: This study was a comprehensive economic analysis of the cost-effectiveness of using the IBS for single-donor apheresis platelets (AP) and random-donor p...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133650/ https://www.ncbi.nlm.nih.gov/pubmed/14604745 http://dx.doi.org/10.1016/S0149-2918(03)80288-6 |